86 research outputs found
Pathological study of non-neoplastic skin lesions by punch biopsy
Background: Accurate diagnosis of skin disorders is of utmost importance as treatment is varied for different skin disorders presenting with the similar clinical lesions. Thus biopsy becomes inevitable in various skin disorders to confirm diagnosis and initiate treatment. The present study was to analyse the age and sex distribution of dermatological disorders presenting to Bhaskar Medical College & Hospital (tertiary care centre), Telangana and assess their histo-pathological profile. The objective was to analyse the histo-pathological profile of skin disorders presenting to the Dermatology department of the hospital, determine the age and sex distribution of various skin diseases and to classify the most common disorders into their subtypes and thus assess the most common subtypes prevalent in the surrounding community.Methods: This was a prospective study carried out at the department of Pathology and department of Dermatology, Bhaskar Medical College & Hospital for a period of three years. Necessary clinical details were obtained in a proforma, punch biopsy taken and sent to the histopathology section for final report. Formalin fixed, paraffin embedded sections were prepared & slides were routinely stained with H & E and special stains applied wherever necessary. Data obtained was tabulated and analysed.Results: Total number of cases analysed were 92. The age group of 21-30 years constituted 31.5% of the total cases. There was a male predominance. Hyperpigmented patch/plaque was the most common clinical lesion (36.9%). Lichenoid lesions was the most common histopathological diagnosis reported (26%) followed by Hansen’s disease(23.9%). Lichen planus was the most common histopathological subtype of lichenoid lesion s(58.3%).
Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12
Chemokines and their ligands play a critical role in enabling chronic lymphocytic leukaemia (CLL) cells access to protective microenvironmental niches within tissues, ultimately resulting in chemoresistance and relapse: disruption of these signaling pathways has become a novel therapeutic approach in CLL. The tyrosine kinase inhibitor dasatinib inhibits migration of several cell lines from solid-organ tumours, but effects on CLL cells have not been reported. We studied the effect of clinically achievable concentrations of dasatinib on signaling induced by the chemokine CXCL12 through its' receptor CXCR4, which is highly expressed on CLL cells. Dasatinib pre-treatment inhibited Akt and ERK phosphorylation in CLL cells upon stimulation with CXCL12. Dasatinib also significantly diminished the rapid increase in actin polymerisation observed in CLL cells following CXCL12 stimulation. Moreover, the drug significantly inhibited chemotaxis in a transwell assay, and reduced the percentage of cells able to migrate beneath a CXCL12-expressing murine stromal cell line. Dasatinib also abrogated the anti-apoptotic effect of prolonged CXCL12 stimulation on cultured CLL cells. These data suggest that dasatinib, akin to other small molecule kinase inhibitors targeting the B-cell receptor signaling pathway, may redistribute CLL cells from protective tissue niches to the peripheral blood, and support the investigation of dasatinib in combination strategies
Synthesis of dibenzyl carbonate: Towards a sustainable catalytic approach
At 90 °C, in the presence of CsF/alpha-Al2O3 or [P8,8,8,1][H3COCO2] as catalysts, a straightforward protocol was set up for the synthesis of dibenzyl carbonate (DBnC) via the transesterification of dimethyl carbonate (DMC) with an excess of benzyl alcohol. The two catalysts were used in amounts as low as 1% mol (with respect to the limiting reagent DMC). Best results were achieved with CsF/alpha-Al2O3 that allowed a simpler and reproducible isolation of DBnC in yields up to 70%. Moreover, both the catalyst and the excess BnOH were recovered and could be recycled. The evaluation of mass index (MI) and cost index for the investigated procedure confirmed the economic sustainability and the choice of a rational mass flow throughout the reaction: the method was in the top 7 among 21 protocols selected as the best available options for the synthesis of DBnC
Selective Catalytic Etherification of Glycerol Formal and Solketal with Dialkyl Carbonates and K2CO3
At T ≥ 200 ◦ C,in the presence of K2CO3 as a catalyst, an original etherification procedure of non-toxic acetals such as glycerol formal (GlyF) and solketal has been investigated by using dialkyl carbonates as safe alkylating agents. The effects of parameters including the temperature, the reaction time, and the loading of both the catalyst and the dialkyl carbonate have been detailed for the model case of dimethyl carbonate (DMC). Both GlyF and solketal were efficiently alkylated by DMC to produce the corresponding O-methyl ethers with selectivity up to 99% and excellent yields (86–99%, by GC). The high selectivity could be accounted for by a mechanistic study involving a combined sequence of methylation, carboxymethylation, decarboxylation and hydrolysis processes. The O-methylation of GlyF and solketal could be successfully scaled up for multigram synthesis even operating with a moderate excess (5 molar equiv.) of DMC and in the
absence of additional solvent. Notwithstanding the advantageous reduction of the process mass index, scale up experiments provided evidence that prolonged reaction times may induce the
decomposition of DMC mainly by the loss of CO2.TheK2CO3-catalyzed etherification of solketal with other carbonates such as dibenzyl and diethyl carbonate (DBnC and DEC, respectively),
proceeded with the same good selectivity observed for DMC. However, at 220 ◦ C, the solketal conversion did not exceed 81% since both DBnC and DEC were extensively consumed in
competitive decarboxylation and hydrolysis reactions
Potential cellular and biochemical mechanisms of exercise and physical activity on the ageing process
Exercise in young adults has been consistently shown to improve various aspects of physiological and psychological health but we are now realising the potential benefits of exercise with advancing age. Specifically, exercise improves cardiovascular, musculoskeletal, and metabolic health through reductions in oxidative stress, chronic low-grade inflammation and modulating cellular processes within a variety of tissues. In this this chapter we will discuss the effects of acute and chronic exercise on these processes and conditions in an ageing population, and how physical activity affects our vasculature, skeletal muscle function, our immune system, and cardiometabolic risk in older adults
New Highly Active and Selective Heterogeneous Catalytic System for the Synthesis of Unsymmetrical Organic Carbonates: A Green Protocol.
Magnesium-Lanthanum Mixed Metal Oxide : a Strong Solid Base for the Michael Addition Reaction.
Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia
Highly efficient "tight fit" immobilization of α-chymotrypsin in mesoporous MCM-41: a novel approach using precursor immobilization and activation
The zymogen α-chymotrypsinogen A is bound to mesoporous silica MCM-41 with a protein loading of 170 mg/g solid (MCM-Z) by a simple stirring in aqueous tris-HCl buffer (pH 7.2). The bound zymogen is then activated with trypsin to obtain α-chymotrypsin immobilized on MCM-41 (MCM-E.I) that displays an effective enzyme activity corresponding to 65 mg protein/g of solid support (3250 BTEE units/g). A direct immobilization of commercially available α-chymotrypsin (MCM-E.II) gives lower loading (1250 BTEE units/g). Protein content of the solid support after immobilization is confirmed by thermogravimetric analysis (TGA). The enzyme is tightly bound to the support and can be used over 100 recycles over 1 week in aqueous as well as reverse micellar media. The immobilized enzyme (MCM-E.I) has been used for resolution of N-acetyl-dl-amino acid esters and racemic trans-4-methoxy-3-phenylglycidic acid (PGA) methyl ester
- …